A wide range of news items about GE HealthCare Technologies (GEHC) from their Q1 2025 earnings call and various share price movements, to FDA approval for their Photonova Spectra CT system are currently catching investor attention. Notably, several prominent financial entities like Piper Sandler and Citi have maintained ratings for GEHC, despite reducing target prices. Meanwhile, Robeco Institutional Asset Management B.V. and Sumitomo Mitsui Trust Group Inc. reflect significant stakeholder interest in GEHC, with their respective $4.23 million stake and recent selling of GEHC shares. In other news, GEHC received a rating upgrade, and presents as a strong value stock in the long term. Nordea Investment Management AB raised its position in GEHC hinting at the potential growth in the forward outlook of the company. Concurrently, Massachusetts Financial Services Co. MA sold a significant number of GEHC shares. Despite recent share price weakness and spin-off from General Electric, GEHC continues to offer value and yield prospects to investors. A consensus rating of 'hold' was received from analysts. Lastly, the company has warned against a below-market mini-tender offer.
Ge Healthcare Technologies GEHC News Analytics from Tue, 12 Aug 2025 07:00:00 GMT to Sat, 18 Apr 2026 04:31:56 GMT -
Rating 6
- Innovation 8
- Information 8
- Rumor 2
